Patents by Inventor Françoise Rohner-Jeanrenaud

Françoise Rohner-Jeanrenaud has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for the treatment of insulin resistance
    Patent number: 9101569
    Abstract: The present invention is directed to a derivative selected from oxytocin, an oxytocin derivative, and an oxytocin agonist useful for the treatment of a disorder selected from obesity and insulin resistance and related methods and pharmaceutical formulations. In particular, the invention relates to a derivative selected from oxytocin, an oxytocin derivative, and an oxytocin agonist useful in the treatment of metabolic syndrome.
    Type: Grant
    Filed: May 17, 2011
    Date of Patent: August 11, 2015
    Assignee: UNIVERSITE DE GENEVE
    Inventors: Françoise Rohner-Jeanrenaud, Nicolas Deblon
  • New Uses of Oxytocin-Like Molecules and Related Methods
    Publication number: 20130085100
    Abstract: The present invention is directed to a derivative selected from oxytocin, an oxytocin derivative, and an oxytocin agonist useful for the treatment of a disorder selected from obesity and insulin resistance and related methods and pharmaceutical formulations. In particular, the invention relates to a derivative selected from oxytocin, an oxytocin derivative, and an oxytocin agonist useful in the treatment of metabolic syndrome.
    Type: Application
    Filed: May 17, 2011
    Publication date: April 4, 2013
    Applicant: UNIVERSITÉ DE GENÈVE
    Inventors: Françoise Rohner-Jeanrenaud, Nicolas Deblon